GlassScriptPhysician profile
Elizabeth Samuel
NPI 1114956539
$6,490.13
in general payments reported to CMS, 2019-2025
42 companies · $1,661 in 2025
The $1,661 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $194 · 2021: $604 · 2022: $821 · 2023: $1,584 · 2024: $1,044 · 2025: $1,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,286 · Education: $3.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,285.72 |
| Education | $3.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,398.89 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Lilly USA, LLC | $508.00 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Lundbeck LLC | $425.98 | 2021-2025 | Vyepti, Rexulti |
| Genzyme Corporation | $408.14 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $364.97 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Pfizer INC. | $364.35 | 2023-2025 | |
| Emd Serono, INC. | $330.75 | 2019-2023 | Mavenclad |
| Tg Therapeutics, INC. | $284.16 | 2025 | |
| Ucb, INC. | $264.01 | 2019-2025 | Rystiggo, Briviact |
| Sk Life Science, INC. | $215.90 | 2021-2023 | Xcopri |
| Eisai INC. | $167.77 | 2022-2024 | |
| Kyowa Kirin, INC. | $165.25 | 2020-2023 | Nourianz |
| Biogen, INC. | $164.51 | 2021-2023 | Vumerity, Tysabri |
| Argenx US, INC. | $141.40 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Acorda Therapeutics, INC | $103.18 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.